http://news.yahoo.com/s/nm/20050919/hl_nm/advertising_dc
U.S. Food and Drug Administration warnings to drug companies over misleading
advertisements have more than tripled in the last year, an agency official
said on Monday.
The agency sent 17 warning letters in the 12 months ending in August
compared with an average of about four to five letters in recent years,
Thomas Abrams, head of FDA's Division of Drug Marketing and Communications,
told food and drug regulatory lawyers at a conference in Washington.
While the increase shows that agency staffers are better able to monitor
materials, Abrams said, it also signals that companies are not doing enough
to present balanced information.
The majority of the 17 letters, about 82 percent, cited companies for not
including information about side effects and other risks in promotional
materials for patients or doctors.
Many offending ads either left out certain serious risks, while others used
very small font size to mention them at the bottom of the page.
"Industry can make efforts to better present risk information," Abrams said.
"This is critical to public health."
About half the letters also warned companies for making false claims about
how well the drug worked, while about 40 percent cited them for wrongly
comparing the featured drug to a competitor, he added.
Abrams said drugmakers should do more to more to comply with advertising
rules, and should present possible problems just as clearly as the drug's
benefits.
"We are continuing to take necessary actions to ensure that prescription
drug promotions have risk information," he said, adding that companies
should voluntarily comply with standards.
Twittering One - 20 Sep 2005 05:17 GMT
Twittering One - 20 Sep 2005 05:18 GMT
Get that Accutane suicide registry up!
Twittering One - 20 Sep 2005 05:27 GMT
If dermatologists and PCPs et al
Would be MORE responsible about monitoring patients
and perform Suicide Risk Screening
Accutane likely could be used safely.
But dermatologists do not act responsibly.
I know this for fact,
as I wrote part of the earlier pregnancy prevention programs
and an embryology teaching module for derms and PCPs.
I saw the data ~
Derms prescibe and monitor irresponsibly.
Dermatologists DO NEED TO MONITOR
for suicide risk
and record accurately in patient records.
If you don't,
you are practicing medicine irresponsibly,
and you may lose a young life,
your patient ~ !
GET with THE PROGRAM
suckers
http://www.ahrp.org/infomail/04/12/07.php
Twittering One - 20 Sep 2005 05:31 GMT
I took that stuff.
It depressed me, too.
Twittering One - 20 Sep 2005 05:39 GMT
TC - 20 Sep 2005 16:21 GMT
> http://news.yahoo.com/s/nm/20050919/hl_nm/advertising_dc
>
[quoted text clipped - 32 lines]
> drug promotions have risk information," he said, adding that companies
> should voluntarily comply with standards.
They sure are getting tough. They are actually writing letters. 17 of
them.
Wow.
Now that is action.
TC
Twittering One - 20 Sep 2005 16:46 GMT
17 to whom
from whom?
TC - 20 Sep 2005 17:38 GMT
> 17 to whom
> from whom?
"The agency sent 17 warning letters in the 12 months ending in August
compared with an average of about four to five letters in recent years,
Thomas Abrams, head of FDA's Division of Drug Marketing and
Communications, told food and drug regulatory lawyers at a conference
in Washington."
If you are unable to read the post, why the f are you responding to it?
TC